Furthermore, these molecules also promote the release of IFN-γ (type II IFN) and upregulate VCAM-1 and MHC-I expression on tumor cells and antigen-presenting cells (APCs), which in turn promote the presentation of tumor antigens [11,26,60,61]. This evidence concerns the gene VCAM1 and neoplasm.